THYMOMA
Clinical trials for THYMOMA explained in plain language.
Never miss a new study
Get alerted when new THYMOMA trials appear
Sign up with your email to follow new studies for THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation after thymoma surgery: could it keep cancer away?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after complete surgical removal of stage II or III thymoma helps prevent the cancer from returning. About 238 adults aged 18 to 75 who had their tumor fully removed will be randomly assigned to receive either radiation or no ad…
Matched conditions: THYMOMA
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Radiation after thymoma surgery: does it keep cancer away?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after surgery can stop thymoma (a rare chest tumor) from returning in patients with stage II or III disease. About 314 adults aged 18-75 who had the tumor completely removed will be randomly assigned to receive radiation or jus…
Matched conditions: THYMOMA
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Promising drug targets rare chest cancers in new trial
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in adults with advanced thymoma or thymic carcinoma that has worsened after at least one prior treatment. The main goal is to see how many patients' tumors shrink or disappear. Participants receive the drug intravenously weekly…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo aims to fight rare thymus cancers after first treatment fails
Disease control Recruiting nowThis phase 2 trial is testing a combination of two drugs—tislelizumab (an immunotherapy) and anlotinib (a targeted therapy)—as a second-line treatment for people with thymoma or thymic carcinoma whose cancer has progressed after initial chemotherapy. The study will enroll 20 part…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Scientists hunt for genetic clues in lung and esophageal cancers
Knowledge-focused Recruiting nowThis study aims to collect tumor, normal tissue, and blood samples from up to 1559 people with cancers of the lung, esophagus, or pleura. Researchers will analyze genetic and epigenetic changes to better understand these diseases and identify potential markers for future treatmen…
Matched conditions: THYMOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Researchers launch major tissue bank to unlock secrets of mesothelioma
Knowledge-focused Recruiting nowThis study aims to collect blood, urine, tumor samples, and health data from up to 1,000 people with malignant mesothelioma or other cancers that express a protein called mesothelin. Participants will be followed over time to track the course of their disease. The goal is to buil…
Matched conditions: THYMOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Massive lung cancer database aims to personalize radiation therapy
Knowledge-focused Recruiting nowThis study is creating a large database of 10,000 lung cancer patients who received radiation therapy. Researchers will collect information on tumor control, side effects, and quality of life to build models that predict outcomes. The goal is to use these models to select the bes…
Matched conditions: THYMOMA
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC